Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ObsEva SA logo — ObsEva. Nature meets Nurture

ObsEva SA

ObsEva. Nature meets Nurture

Founded 2012 Switzerland Plan-les-ouates, Switzerland 9 employees Post-IPO Debt Total: $227.00M Biotechnology, Health and Wellness +2

General Information

Company Name ObsEva SA
Founded Year 2012
Location Switzerland Plan-les-ouates, Switzerland
Founders / Decision Makers
Team member Team member
Employees 9
Industries Biotechnology, Health and Wellness, Pharmaceutical +1
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with ObsEva SA. To contact ObsEva SA, visit obseva.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ObsEva SA compare?

A PDF of ObsEva SA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ObsEva SA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ObsEva SA

ObsEva SA is a Swiss-based biopharmaceutical company founded in 2012 with a focus on innovating women’s reproductive health and pregnancy therapeutics. The company's slogan, "ObsEva. Nature meets Nurture," reflects its commitment to addressing serious conditions that compromise women's reproductive health. ObsEva is currently in the clinical stage of developing and commercializing novel therapeutics for these conditions. The latest significant funding for ObsEva was a $75.00M post-IPO debt investment on 08 August 2019, with Oxford Finance being the investor. The company's dedication to improving women's health through groundbreaking biotechnology and pharmaceutical solutions positions it as a promising venture for potential investors seeking opportunities in the healthcare industry. For additional details, visit www.ObsEva.com.

Business keywords: Clinical-stage biopharmaceutical, Reproductive health, Pregnancy therapeutics, Women's health, Swiss-based company, Preterm labor, Innovative drugs, Female reproductive medicine, Biopharmaceutical industry, Ernest Loumaye, André Chollet, Medicinal and pharmaceutical chemistry, Drug development, Specialty biopharmaceutical company, Clinical development

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $75.00M 1
Oxford Finance LLC
08 Aug 2019
Post IPO Equity $60.00M 8
New Enterprise Associates New Leaf Venture Partners Venrock
New Enterprise Associates, New Leaf Venture Partners +6
10 Oct 2017
Series B Fr.60.00M 1
New Enterprise Associates
New Enterprise Associates
23 Nov 2015
Series A Fr.32.00M -
29 Aug 2013
Seed Round Undisclosed -
01 Jan 2013

ObsEva SA Alternatives & Competitors

View All Alternatives
ObsEva SA vs
Forma Therapeutics
Forma Therapeutics United States

Dedicated to transforming the lives of patients with rare hematologic diseases and cancers.

Series D
159 employees
Biotechnology, Health Care
ObsEva SA vs
Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. United States

Targeted Therapy Delivered

Acquired
39 employees
Biotechnology, Health and Wellness
ObsEva SA vs
Tetralogic Pharmaceuticals
Tetralogic Pharmaceuticals

TetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused on d...

Convertible Note
10 employees
Biotechnology, Health Care
View all alternatives

FAQ About ObsEva SA

ObsEva. Nature meets Nurture
ObsEva SA was founded in 2012.
ObsEva SA is headquartered in Plan-les-ouates, Switzerland.
ObsEva SA operates in Biotechnology, Health and Wellness, Pharmaceutical and Women's Health. Its work centres on Clinical-stage biopharmaceutical, Reproductive health, Pregnancy therapeutics and Women's health.
ObsEva SA has approximately 9 employees.
ObsEva SA has completed 5 funding rounds, raising a total of $227.00M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to ObsEva SA include Forma Therapeutics, Lisata Therapeutics, Inc., Tetralogic Pharmaceuticals, Antios Therapeutics, Cholesgen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ObsEva SA and Forma Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ObsEva SA, https://bouncewatch.com/company/obseva-sa, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes